ibafloxacin has been researched along with ciprofloxacin in 2 studies
*Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline. [MeSH]
*Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, JM; Diver, JM; Piddock, LJ; Wise, R | 1 |
| Bodey, GP; Ho, DH; LeBlanc, B; Rolston, KV | 1 |
2 other study(ies) available for ibafloxacin and ciprofloxacin
| Article | Year |
|---|---|
In vitro studies of S-25930 and S-25932, two new 4-quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Edetic Acid; Enterobacteriaceae; Gram-Positive Bacteria; Humans; Kinetics; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines; Quinolizines | 1986 |
In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gram-Negative Bacteria; Humans; Naphthyridines; Neoplasms; Quinolizines | 1987 |